To explore the downstream target genes of NCOA3 on CRC development, we knocked down MAD2L2 in HCT116 cells and found that NCOA3 activates the key targets of PI3K/AKT and Notch signaling pathway in RNA levels, which are involved in CRC progression (Fig. 4A). Here, NCOA3 is linked to colorectal carcinoma.